ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

VERV Verve Therapeutics Inc

6,05
-0,33 (-5,17%)
18 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Verve Therapeutics Inc VERV NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,33 -5,17% 6,05 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,33 5,8997 6,34 5,98 6,38
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.5.202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202413:15EDGAR2Form 8-K - Current report
08.5.202413:00GLOBEVerve Therapeutics Announces Pipeline Progress and Reports..
07.5.202413:00GLOBEVerve Therapeutics Announces Dosing of First Patient in..
03.5.202422:01GLOBEVerve Therapeutics Announces Inducement Grants under Nasdaq..
02.4.202413:00GLOBEVerve Therapeutics Announces Updates on its PCSK9 Program
28.3.202421:51GLOBEVerve Therapeutics Announces Inducement Grants under Nasdaq..
01.3.202422:01GLOBEVerve Therapeutics Announces Inducement Grants under Nasdaq..
27.2.202414:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
27.2.202414:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27.2.202413:45EDGAR2Form 8-K - Current report
27.2.202413:30GLOBEVerve Therapeutics Provides Pipeline Progress and Reports..
16.2.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202412:30GLOBEVerve Therapeutics to Participate in the Guggenheim..
02.1.202412:30GLOBEVerve Therapeutics to Present at the 42nd Annual J.P. Morgan..
01.12.202322:00GLOBEVerve Therapeutics Announces Closing of Public Offering of..
29.11.202322:54EDGAR2Form 8-K - Current report
29.11.202322:47EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29.11.202312:47DJNVerve Therapeutics Shares Tumble Premarket After Stock Sales
29.11.202304:37GLOBEVerve Therapeutics Announces Pricing of Public Offering of..
28.11.202322:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.11.202322:01GLOBEVerve Therapeutics Announces Proposed Public Offering of..
13.11.202312:34EDGAR2Form 8-K - Current report
12.11.202321:30GLOBEVerve Therapeutics Announces Interim Data for VERVE-101..
07.11.202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.11.202313:00EDGAR2Form 8-K - Current report
07.11.202312:30GLOBEVerve Therapeutics Highlights Recent Company Progress and..
31.10.202311:59DJNBeam Therapeutics to Sell Rights in Verve Licensing Deal to..
31.10.202311:01GLOBEVerve and Lilly Relationship Expands to Include Verve’s In..
23.10.202313:22DJNVerve Therapeutics Gets Clinical Hold For VERVE-101 Lifted..
23.10.202312:41EDGAR2Form 8-K - Current report
23.10.202312:30GLOBEVerve Therapeutics Announces Clearance of Investigational..
26.9.202312:30GLOBEVerve to Present Interim Data from the heart-1 Phase 1b..
21.9.202322:05GLOBEVerve Therapeutics to Participate in the 2023 Cantor Global..
18.9.202312:30GLOBEVerve Expands Leadership Team with Appointment of Frederick..
10.8.202313:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202313:00EDGAR2Form 8-K - Current report
10.8.202312:30GLOBEVerve Therapeutics Highlights Recent Company Progress and..
03.8.202312:30GLOBEVerve Therapeutics to Present at the Canaccord 43rd Annual..
15.6.202313:16DJNVerve Therapeutics Strikes Gene Editing Deal With Eli Lilly
15.6.202312:30GLOBEVerve Establishes Global Collaboration with Lilly to Advance..
01.6.202312:30GLOBEVerve Therapeutics to Participate in the 2023 Jefferies..
23.5.202312:30GLOBEVerve Therapeutics to Participate in the Stifel 2023..